significantly associated with poor OS than those of lower values. However, no association was observed between the mFI <0.18 and !0.18.
INTRODUCTION AND OBJECTIVES:
We hypothesized that ureteral stent urine culture (UC) results may predict urinary tract infection(UTI)-related readmissions following robotic radical cystectomy with ileal conduit diversion (RCIC). Starting in 2015, we adopted a strict stent removal protocol to include stent urine culture (UC) and a single dose IV antibiotic given prior to removal targeted for postoperative day 4. We analyzed the results of this coordinated effort.
METHODS: This is a single center analysis of a prospectively collected cystectomy dataset from 4/2015 to 1/2018. The patients were divided according to stent culture results into the positive cohort ( single or multiple organism with CFU>1,000) and negative cohort (no growth, contaminated results or organism/s growth with <1,000 CFU). Measured outcomes were 90-day Urinary Adverse Events (UAE; UTI requiring inpatient or outpatient antibiotics within our institutional system or by outside report), overall-readmission rate and UTI-related readmission rates. Fisher's exact tests were used to compare rates and logistic regression was used to estimate odds ratios (OR).
RESULTS: 202 patients underwent RCIC between 4/2015 and 1/ 2018. 146 patients had complete data and were included in the analysis. There were 70 patients in the positive group and 76 in the negative group. There was no statistically significant difference in the median age, gender, racial makeup, median Charlson Comorbidity Index (CCI), median ASA score, pathological stage or percentage of patients who underwent preoperative chemotherapy between both groups. The outcomes are summarized in the table. Multivariable logistic regression analysis concluded that a positive stent culture predicted higher UTI-related readmission rate (OR[4.19, 95%CI:1.16, 15.11, .
CONCLUSIONS: A positive stent culture was significantly associated with increased 90-day UTI-related readmission rate. There was no correlation with UAE or total readmission rates. Further analysis is warranted to study whether the organisms isolated with positive stent culture correlated with organisms isolated during UTIrelated readmission episodes. Readmission incidence or severity could be mitigated by earlier, more precise antibiotic use and possibly use of prophylactic antibiotics per stent culture results. METHODS: We retrospectively analyzed an IRB-approved, prospectively collected RCUD dataset. We included adult RCUD patients diagnosed with malignancy from January 2014 through January 2018. Cohorts were divided according to scintigraphy excretion half-life (<10 minutes vs !10 minutes) and sidedness of significant scintigraphy results. Our endpoints were ipsilateral UES, 90-day readmission and urinary-source related readmission. UES was defined as evidence of obstruction on imaging associated with recurrent pyelonephritis, persistent flank pain or worsening renal function. Fischer's exact test, t-test and multivariable logistic regression were used for analysis.
RESULTS: 144 patients had complete data and underwent analysis. There was no difference in the cohorts with respect to race, age, gender, surgical approach, diversion type, pathological staging, neoadjuvant chemotherapy or history of radiotherapy to the abdomen or pelvis. Table 1 summarizes univariate analysis of outcomes. On multivariate analysis, a half-life!10 minutes predicted a higher UES for the left p[0.011) and right sides p[0.015) . A left half-life!10 had a higher 90-day readmission (OR 2.92 95% CI 1. 34-6.36, p[0.007) . The negative predictive value (NPV) for future UES if half-life<10 minutes was 90% and 92% for the right and left kidneys respectively. CONCLUSIONS: Lasix renal scintigraphy appears to be associated with an increased rate of UES and 90-day readmission rate following RCUD. Importantly, a UES in the setting of a normal renal scan (1/2 life < 10 min) following RCUD is unlikely with a NPV exceeding 90%. Future efforts will be directed towards determining its clinical and cost effectiveness as compared to other radiographic modalities
